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Background: Altered somatotrophic signaling is among the most important potential mechanisms of extended
longevity. Ames dwarf (df/df) mice are homozygous for mutation at the Prop-1 gene, leading to a lack of growth
hormone (GH), prolactin and thyroid stimulating hormone (TSH). Mice homozygous for targeted disruption of the
growth hormone receptor/growth hormone binding protein gene are known as GH receptor knockout (GHRKO)
mice or “Laron dwarf”. Both, df/df and GHRKO mice, are characterized by reduced body size, low plasma insulin and
insulin-like growth factor-I (IGF-I), remarkably extended longevity, and severe (in df/df mice) or mild (in GHRKO
mice) thyroid hypofunction. Recently, by crossing df/df and GHRKO mice, double-mutant Ames dwarf/GHRKO
(df/KO) mice were created. Interestingly, these mice are smaller than Ames dwarfs or GHRKOs, and also have
reduced insulin and IGF-I levels. The aim of the study was to investigate if and to what extent certain thyroid
morphological parameters, such as inner follicular surface area, inner follicular perimeter, as well as the follicular
epithelium thickness are changed in the examined dwarf mice.
Methods: This quantification was performed in thyroids collected from df/df, GHRKO and df/KO female mice, at
approximately 5–6 months of age. We used a computerized plotting programme that combines a live microscopic
image of the slide with an operator-generated overlay.
Results: Inner follicular surface area and inner follicular perimeter were decreased in all examined kinds of dwarf
mice as compared to normal animals. Furthermore, decreases in these two parameters were more pronounced in
df/df and df/KO than in GHRKO mice. Concerning the follicular epithelium thickness, only a tendency towards
decrease of this parameter was found in all three kinds of dwarf mice.
Conclusions: Parameters characterizing thyroid follicle size are decreased in all three examined models of dwarf
mice, which may explain decreased thyroid hormone levels in both basal mutants (Ames dwarfs and GHRKOs).
df/df mutation seems to predominate over GHRKO genetic intervention concerning their effects on thyroid growth.
Beside TSH, also GH signaling seems to constitute a crucial element in the regulation of thyroid growth and,
possibly, function.
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The thyroid gland plays a crucial role, through thyroid
hormones (TH) synthesis, in the regulation of various
physiological processes, including development of the
central nervous system, skeletal growth or heat produc-
tion. The synthesis of TH is regulated by hypothalamus-
pituitary-thyroid axis in the negative feedback loop. Also
concerning the regulation of thyroid growth processes,
the hypothalamus-pituitary-thyroid axis constitutes the
main mechanism, with thyroid stimulating hormone
(TSH) being the strongest stimulatory factor for thyroid
hyperplasia and proliferation. However, the role of other
factors, such as, for example, insulin-like growth factor-I
(IGF-I) or epidermal growth factor (EGF), in thyroid de-
velopment, growth and function, is considered and,
partially, documented [1-4]. The possible strong contri-
bution of factors other than “classical” to the regulation
of thyroid growth and function is further supported by
the following observation. It has been recently found
that iodine-deficient diet does not induce thyroid en-
largement, whereas decreasing thyroxine secretion in
Slc26a4-null mutant mice, being an experimental model
for Pendred syndrome [5].
Concerning external factors, iodine deficiency is
proven to be the most common cause of thyroid en-
largement, leading to goiter formation [1]. Importantly,
a high prevalence of goiter is observed in patients with
acromegaly [characterized by increased growth hormone
(GH) synthesis and elevated IGF-I level] [6]. Further-
more, the increased prevalence of thyroid cancer in
acromegalic patients is observed [7,8]. In turn, the trans-
genic mice over-expressing GH, which may constitute
an experimental model of acromegaly, are characterized
by increased adult body mass and drastically shortened
lifespan [9].
In agreement with the above, experimental evidence
suggests that reduced GH signaling may contribute to
lifespan extension. Therefore, several types of laboratory
animals with disruption of somatotrophic axis are used
in aging research. The animals with altered somato-
trophic signaling are, among others, Ames dwarf (df/df )
mice. These rodents are homozygous for a spontaneous
recessive mutation at the transcription factor Prop-1,
leading to a lack of GH (with undetectable plasma level
of IGF-I), prolactin (Prl) and TSH [10]. The absence of
GH, Prl and TSH is a consequence of hypofunctional
development of the anterior pituitary and a failure of dif-
ferentiation of lactotrophs, somatotrophs and thyro-
trophs [10]. Interestingly, these dwarf mice live much
longer than their normal siblings [11] and are character-
ized by delayed aging [12], small body size and delayed
puberty [13]. Moreover, Ames dwarfs have decreased
plasma glucose and insulin levels [13], enhanced insulin
sensitivity [14], reduced body core temperature [15],enhanced mitochondrial function [16] and importantly,
they are severely hypothyroid [13].
Another experimental model characterized by pro-
longed lifespan results from genetic intervention which
relies on the targeted disruption of the GH receptor/GH
binding protein gene (Ghr/bp gene) [17]. Mice homozy-
gous for this mutation are known as GH receptor/GH
binding protein knockout (GHRKO; Ghr/bp −/−) mice or
“Laron dwarf” [17]. These GH-resistant mice also live
longer than their normal siblings and are characterized by
reduced mass and body size, undetectable level of GH
receptors, high level of serum GH, greatly reduced
plasma levels of insulin and IGF-I, enhanced insulin sen-
sitivity, reduced oxidative damage and improved oxidative
stress resistance [13,17-26]. Furthermore, GHRKO mice
have lower incidence and delayed onset of fatal neoplastic
diseases [27]. The mice with disrupted GH receptor are
also characterized by decreased levels of pro-apoptotic
factors [28-30] and increased levels of key regulators of
mitochondrial biogenesis [31,32]. Importantly, GHRKO
mice may have decreased thyroid hormone levels [33],
however the results are not consistent [33,34]. Presum-
ably, the differences in levels of thyroid hormones
in GHRKO mice may be gender- and age-dependent
[33,34]. Similar observations, showing gender-specific
changes in thyroid hormones levels in humans during
aging, were reported by Suzuki et al. [35].
Interestingly, by crossing df/df and GHRKO mice,
double-mutant Ames dwarf/GHRKO (df/KO) mice have
been recently created. These mice lacking circulating GH
and GH receptor are smaller than Ames dwarfs or
GHRKOs, and also have reduced insulin and IGF-I levels
[36].
The aim of the study was to investigate if and to what
extent certain thyroid morphological parameters, such as
inner follicular surface area, inner follicular perimeter, as
well as the follicular epithelium thickness are changed in
the examined dwarf mice.
Methods
Animals
Normal mice (N; n = 5), Ames dwarf mice (df/df; n = 5),
growth hormone receptor knockout mice, derived from
animals kindly provided by Dr. J.J. Kopchick (Ohio Uni-
versity, Athens, OH, USA) (GHRKO; n = 7) and double-
mutant Ames dwarf/GHRKO mice (df/KO; n = 7) (all
females) were bred and maintained under temperature-
and light-controlled conditions (22 ± 2°C, 12 hr light/
12 hr dark cycle). At 5–6 months of age, the animals
were anesthetized and euthanized by decapitation. After
decapitation, thyroid lobes were collected and fixed in
10% formalin for 6 hours, and, next, in 70o alcohol. Then,
the procedure of embedding of thyroid lobes in paraffin
wax (using 95o alcohol, aniline, carboxylene, xylene and,
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tions (4 μm thick), after deparaffinating, were stained
with hematoxylin and eosin.
Assessment of thyroid morphological parameters
In order to evaluate the inner follicular surface area,
inner follicular perimeter and follicular epithelium thick-
ness, a computerized microscopy analysis system (Neu-
rolucida, MicroBright Field Inc, Colchester, VT, USA)
was used. This programme combines a live microscopic
image of the slide with an operator-generated overlay.
Statistical analysis
The data were statistically analysed, using Student’s un-
paired t test or the one-way analysis of variance
(ANOVA), followed by Student-Newman-Keuls’ test.
Statistical significance was determined at the level of
p<0.05. The results, obtained from the right and left
lobes, are jointly depicted in the figures and expressed as
means ± SEM. All statistical calculations were conducted
using SPSS version 17.0 (SPSS, Chicago, IL) with α=0.05.
All graphs were made using Prism 4.02 (GraphPad Soft-
ware, San Diego, CA).
Results
Inner follicular surface area was decreased in Ames
dwarf (df/df ), GHRKO and double-mutant Ames dwarf/
GHRKO mice (df/KO) as compared to normal animals
(p<0.001 all) (Figure 1). Moreover, this morphological
parameter was also decreased in df/df and df/KO mice
in comparison with GHRKO dwarfs (p = 0.034, p = 0.04,
respectively) (Figure 1). No changes in inner follicular
surface area between df/df and df/KO mice were
observed (Figure 1). Similarly to inner follicular surface
area, also inner follicular perimeter was decreased in df/












Figure 1 Inner follicular surface area. Inner follicular surface area
in normal (N), growth hormone receptor/binding protein knockout
(GHRKO), Ames dwarf (df/df) and double-mutant Ames
dwarf/GHRKO (df/KO) mice. Values are means ± SEM. a – p<0.001
vs. normal mice; b – p<0.05 vs. GHRKO mice.animals (p<0.001 all) (Figure 2). The inner follicular per-
imeter was also decreased in df/df and df/KO mice in
comparison with GHRKO animals (p = 0.039, p = 0.028,
respectively) (Figure 2). Furthermore, this parameter did
not differ between df/df and df/KO mice (Figure 2).
Concerning the follicular epithelium thickness, only a
tendency towards decrease of this parameter in all kinds
of the examined dwarf mice was found (Figure 3).
Discussion
We have expectedly observed in our study that the inner
follicular surface area and the inner follicular perimeter
were decreased in all examined kinds of dwarf mice. At
least two causes of such results can be considered. First,
the decrease of these parameters may be a direct conse-
quence of smaller sizes and masses of Ames dwarf (df/
df ), GHRKO and df/KO mice as compared to normal
animals. In accordance with our observation, Bartke [37]
reported previously that the thyroid glands of Ames
dwarfs and Snell mice (another kind of dwarf mice, char-
acterized by a mutation at the transcription factor Pit-1
[38]) were greatly reduced in size, the follicles were small,
and in the center of each lobe a considerable amount of
the tissue was not organized into follicles. Similarly, Cor-
dier et al. [39] demonstrated reduced follicular para-
meters (e.g. follicular surface and volume) in Snell mice
as compared to normal mice. According to such an ex-
planation, even lower values of measured parameters
should be observed in double mutants, i.e. df/KO, as they
are characterized by smaller body mass and size when
compared to df/df or GHRKO mice [36]. However, both,
the inner follicular surface area and the inner follicular
perimeter in double mutants df/KO were the same as in
case of df/df mice. This means that the additional experi-
mental intervention, namely GHRKO, did not add any-









Figure 2 Inner follicular perimeter. Inner follicular perimeter in
normal (N), growth hormone receptor/binding protein knockout
(GHRKO), Ames dwarf (df/df) and double-mutant Ames
dwarf/GHRKO (df/KO) mice. Values are means ± SEM. a – p<0.001
vs. normal mice; b – p<0.04 vs. GHRKO mice.











Figure 3 Follicular epithelium thickness. Follicular epithelium
thickness in normal (N), growth hormone receptor/binding protein
knockout (GHRKO), Ames dwarf (df/df) and double-mutant Ames
dwarf/GHRKO (df/KO) mice. Values are means ± SEM.
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meters between df/KO and df/df mice suggests that some
additional factors could exist, being responsible for such
result, and presumably it may be linked to thyroid secret-
ing function. Thus, the second cause may relate to cer-
tain factors which decrease thyroid function much
stronger in df/df mice [13] than in GHRKO animals [33].
Thus, on the basis of our results we can suggest that df/
df mutation predominates over GHRKO genetic inter-
vention concerning their effects on thyroid growth and,
possibly, function. However, further analysis of thyroid
function in df/KO mice is needed.
It is clear that the interruption of somatotrophic axis
(at different levels) is responsible for the smaller body
mass, smaller body size and smaller size of different
organs, thyroid included, in dwarf mice. In this context,
it is worth stressing that IGF-I acts also locally in the
thyroid gland, e.g. via enzymes involved in DNA synthe-
sis [40]. Furthermore, IGF-I may contribute to thyroid
cancers development [41]. Therefore, the somatotrophic
signaling can also be reduced in this endocrine gland in
dwarf mice, what may, presumably, lead to the decrease
of the examined thyroid morphological parameters.
Furthermore, decreased inner follicular surface area
and inner follicular perimeter in dwarf mice may suggest
smaller amount of colloid in the thyroid gland. It is
known that decreased colloid content is observed in
hyperthyroidism. In contrast, df/df and GHRKO mice
are characterized, as was reported above, by severe (in
df/df mice) or mild (in GHRKO mice) thyroid hypofunc-
tion. However, one should conclude that results from
the present study can not be directly extrapolated into
the studies in humans. Even contradictory results have
been obtained between experimental studies in humans.
For example, whereas decreased oxidative stress was
found in dwarf mice [13], huge oxidative damage to
membrane lipids was reported in GH-deficient patients[42,43], the phenomenon which was partially reversed
by GH replacement [43].
Interestingly, both GH and IGF-I increased the iron-
induced lipid peroxidation (LPO) in porcine thyroid
homogenates [44]. On the other hand, GH and IGF-I
may prevent the iron-induced oxidative damage in other
tissues [45]. These results suggest that somatotrophic
axis may reveal either pro-oxidative or anti-oxidative ac-
tion, depending on the current redox status. This, in
turn, may contribute to the regulation of thyroid growth
and function [46].
The results of the present study are important not only
in the context of longevity. There is a strong relationship
between thyroid function, GH–IGF-I axis and bone lin-
ear growth in animals and humans. It is well known that
thyroid hormones are indispensable for bone linear
growth. Additionally, untreated hypothyroidism un-
favourably affects the results of replacement therapy in
GH-deficient patients and also it disturbes the results
during diagnosis [47,48]. Thus, further studies, morpho-
logical evaluation included, on the thyroid function in
subjects with disturbed GH–IGF-I axis would be of great
importance.
Taking into account all above observations, one should
hypothesize that GH signaling may contribute to thyroid
growth and/or function, and that thyroid function (and/or
morphological development) may be somehow affected by
somatotrophic axis, although various other factors contrib-
uting to the development of thyroid gland are also known.
Conclusions
Parameters characterizing thyroid follicle size are
decreased in all examined kinds of dwarf mice, which
may explain decreased thyroid hormone levels in both
basal mutants (Ames df/df dwarfs and GHRKOs). df/df
mutation seems to predominate over GHRKO genetic
intervention concerning their effects on thyroid growth.
Beside TSH, also GH signaling seems to constitute a cru-
cial element in thyroid growth and, possibly, function.
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